ArticleFrontiers in oncology2021

Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.

Qitong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.